Literature DB >> 22341972

Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man.

Karin Tuschl1, Peter T Clayton, Sidney M Gospe, Shamshad Gulab, Shahnaz Ibrahim, Pratibha Singhi, Roosy Aulakh, Reinaldo T Ribeiro, Orlando G Barsottini, Maha S Zaki, Maria Luz Del Rosario, Sarah Dyack, Victoria Price, Andrea Rideout, Kevin Gordon, Ron A Wevers, W K Kling Chong, Philippa B Mills.   

Abstract

Environmental manganese (Mn) toxicity causes an extrapyramidal, parkinsonian-type movement disorder with characteristic magnetic resonance images of Mn accumulation in the basal ganglia. We have recently reported a suspected autosomal recessively inherited syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia in cases without environmental Mn exposure. Whole-genome mapping of two consanguineous families identified SLC30A10 as the affected gene in this inherited type of hypermanganesemia. This gene was subsequently sequenced in eight families, and homozygous sequence changes were identified in all affected individuals. The function of the wild-type protein and the effect of sequence changes were studied in the manganese-sensitive yeast strain Δpmr1. Expressing human wild-type SLC30A10 in the Δpmr1 yeast strain rescued growth in high Mn conditions, confirming its role in Mn transport. The presence of missense (c.266T>C [p.Leu89Pro]) and nonsense (c.585del [p.Thr196Profs(∗)17]) mutations in SLC30A10 failed to restore Mn resistance. Previously, SLC30A10 had been presumed to be a zinc transporter. However, this work has confirmed that SLC30A10 functions as a Mn transporter in humans that, when defective, causes Mn accumulation in liver and brain. This is an important step toward understanding Mn transport and its role in neurodegenerative processes. Copyright Â
© 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341972      PMCID: PMC3309187          DOI: 10.1016/j.ajhg.2012.01.018

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  57 in total

1.  Follow-up of patients affected by manganese-induced Parkinsonism after treatment with CaNa2EDTA.

Authors:  Elena Herrero Hernandez; Gianluigi Discalzi; Consuelo Valentini; Fabrizio Venturi; Adriano Chiò; Caterina Carmellino; Luigi Rossi; Anna Sacchetti; Enrico Pira
Journal:  Neurotoxicology       Date:  2005-11-04       Impact factor: 4.294

Review 2.  Manganese and its role in Parkinson's disease: from transport to neuropathology.

Authors:  Michael Aschner; Keith M Erikson; Elena Herrero Hernández; Elena Herrero Hernández; Ronald Tjalkens
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

3.  Functional expression in yeast of the human secretory pathway Ca(2+), Mn(2+)-ATPase defective in Hailey-Hailey disease.

Authors:  Van-Khue Ton; Debjani Mandal; Cordelia Vahadji; Rajini Rao
Journal:  J Biol Chem       Date:  2001-12-06       Impact factor: 5.157

4.  Portal-systemic encephalopathy: report of a case with unusual MR findings.

Authors:  A Uchino; T Aoki; M Ohno
Journal:  Radiat Med       Date:  1993 Jan-Feb

5.  Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis.

Authors:  S M Gospe; R D Caruso; M S Clegg; C L Keen; N R Pimstone; J M Ducore; S S Gettner; R A Kreutzer
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

Review 6.  Manganese neurotoxicity.

Authors:  Allison W Dobson; Keith M Erikson; Michael Aschner
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

7.  Alterations in cellular IRP-dependent iron regulation by in vitro manganese exposure in undifferentiated PC12 cells.

Authors:  Catherine L Kwik-Uribe; Stephen Reaney; Zhiwu Zhu; Donald Smith
Journal:  Brain Res       Date:  2003-05-23       Impact factor: 3.252

Review 8.  Manganism and idiopathic parkinsonism: similarities and differences.

Authors:  D B Calne; N S Chu; C C Huang; C S Lu; W Olanow
Journal:  Neurology       Date:  1994-09       Impact factor: 9.910

9.  A Parkinsonian syndrome in methcathinone users and the role of manganese.

Authors:  Ainārs Stepens; Ināra Logina; Viesturs Liguts; Pauls Aldins; Ilze Eksteina; Ardis Platkājis; Inese Mārtinsone; Elmārs Tērauds; Baiba Rozentāle; Michael Donaghy
Journal:  N Engl J Med       Date:  2008-03-06       Impact factor: 91.245

10.  High dietary iron reduces transporters involved in iron and manganese metabolism and increases intestinal permeability in calves.

Authors:  S L Hansen; M S Ashwell; A J Moeser; R S Fry; M D Knutson; J W Spears
Journal:  J Dairy Sci       Date:  2010-02       Impact factor: 4.034

View more
  123 in total

Review 1.  Update on the Diagnosis and Management of Wilson Disease.

Authors:  Eve A Roberts
Journal:  Curr Gastroenterol Rep       Date:  2018-11-05

2.  Manganese transporter genetics and sex modify the association between environmental manganese exposure and neurobehavioral outcomes in children.

Authors:  Karin Broberg; Tahir Taj; Stefano Guazzetti; Marco Peli; Giuseppa Cagna; Daniela Pineda; Donatella Placidi; Robert O Wright; Donald R Smith; Roberto G Lucchini; Karin Wahlberg
Journal:  Environ Int       Date:  2019-06-22       Impact factor: 9.621

3.  Parkinsonian syndrome and ataxia as a presenting finding of acquired hepatocerebral degeneration.

Authors:  Vladimir Miletić; David Ozretić; Maja Relja
Journal:  Metab Brain Dis       Date:  2014-01-05       Impact factor: 3.584

4.  Two-year follow-up after chelating therapy in a patient with adult-onset parkinsonism and hypermanganesaemia due to SLC30A10 mutations.

Authors:  L Di Toro Mammarella; A Mignarri; C Battisti; L Monti; V Bonifati; F Rasi; A Federico
Journal:  J Neurol       Date:  2013-11-26       Impact factor: 4.849

5.  Manganese transport and toxicity in polarized WIF-B hepatocytes.

Authors:  Khristy J Thompson; Jennifer Hein; Andrew Baez; Jose Carlo Sosa; Marianne Wessling-Resnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-24       Impact factor: 4.052

Review 6.  Exposure, epidemiology, and mechanism of the environmental toxicant manganese.

Authors:  Pan Chen; Megan Culbreth; Michael Aschner
Journal:  Environ Sci Pollut Res Int       Date:  2016-04-22       Impact factor: 4.223

7.  Investigating the role of transferrin in the distribution of iron, manganese, copper, and zinc.

Authors:  Carolina Herrera; Michael A Pettiglio; Thomas B Bartnikas
Journal:  J Biol Inorg Chem       Date:  2014-02-25       Impact factor: 3.358

8.  Ferroportin deficiency impairs manganese metabolism in flatiron mice.

Authors:  Young Ah Seo; Marianne Wessling-Resnick
Journal:  FASEB J       Date:  2015-03-17       Impact factor: 5.191

9.  Hypothyroidism induced by loss of the manganese efflux transporter SLC30A10 may be explained by reduced thyroxine production.

Authors:  Chunyi Liu; Steven Hutchens; Thomas Jursa; William Shawlot; Elena V Polishchuk; Roman S Polishchuk; Beth K Dray; Andrea C Gore; Michael Aschner; Donald R Smith; Somshuvra Mukhopadhyay
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

Review 10.  C. elegans as a model in developmental neurotoxicology.

Authors:  Joanna A Ruszkiewicz; Adi Pinkas; Mahfuzur R Miah; Rebecca L Weitz; Michael J A Lawes; Ayodele J Akinyemi; Omamuyovwi M Ijomone; Michael Aschner
Journal:  Toxicol Appl Pharmacol       Date:  2018-03-14       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.